CDK5 and non-small cell lung carcinoma: In pathological grading III, the positive expression of CDK5 was 66.2 % (86/130) in the cases of NSCLC higher than that in pathological grading I (25.6 %, 10/39)and II (42.4 %, 39/92, both P < 0.001, Table 4).